Get 40% Off
🚨 Volatile Markets? Find Hidden Gems for Serious Outperformance
Find Stocks Now

EssilorLuxottica quarterly sales recover as second virus wave looms

Published 03/11/2020, 07:07
Updated 03/11/2020, 07:41
© Reuters. Sunglasses from Ray Ban are on display at a optician shop in Hanau near Frankfurt

(Reuters) - EssilorLuxottica (PA:ESLX) said on Tuesday its third-quarter sales showed signs of recovery, but the maker of Oakley and Ray-Ban eyes the next few months with 'prudent confidence' as a second coronavirus wave threatens another heavy blow to results.

The company also said it would, in December, consider whether to pay a dividend by year-end, having suspended it in March along with scrapping its guidance for the year.

Sales in the quarter ended Sept. 30 fell 1.1% at constant currencies from a year earlier to 4.09 billion euros (3.69 billion pounds), recovering some ground after almost halving in the second quarter as lockdowns eased and stores reopened.

The company said more than 95% of its stores had reopened globally by the end of September.

EssilorLuxottica said in a statement that it was "confident about the structural resilience of optical needs" although "cautious about the near-term evolution of COVID-19 and about the amount of pent-up demand potentially fuelling the current recovery".

The company, formed as a merger between French lens manufacturer Essilor and Italian spectacles maker Luxottica, confirmed its target of net synergies, or cost efficiencies, from the merger of 420 million euros to 600 million euros for adjusted operating profit by 2023.

EssilorLuxottica, which makes eyewear for luxury brands such as Chanel, Prada and Versace, added revenue synergies had been somewhat delayed by temporary store closures but were gradually catching up.

Dutch Opticians group GrandVision (AS:GVNV), for which the company has made a 7.2 billion euro bid, said in October it had returned to revenue growth in the third quarter but did not provide an outlook for the fourth quarter and 2021.

3rd party Ad. Not an offer or recommendation by Investing.com. See disclosure here or remove ads .

EssilorLuxottica said in September it would appeal against a Dutch court's verdict that had rejected its contention that GrandVision had breached a deal agreement during the pandemic.

GrandVision has said it is supporting EssilorLuxottica in obtaining the remaining regulatory approvals, which are not affected by the appeal, for the planned takeover.

Latest comments

Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
© 2007-2024 - Fusion Media Limited. All Rights Reserved.